Current ad hoc announcements

Geratal, February 7, 2024. The Supervisory Board and Management Board have extended the current Management Board contract by a further 3 years until December 31, 2027 in order to continue to ensure…

The update of the AlsterResearch study on the Geratherm Group published on August 28, 2023 continues to give a buy recommendation with an unchanged price target of EUR 11.30. Despite sluggish sales in…

The update of the AlsterResearch study on the Geratherm Group, published on June 29, 2023, once again confirms the price target of EUR 11.30 with a clear buy recommendation. The reasons for this are…

Geratal, January 17, 2023. At the last meeting of the Supervisory Board, the Supervisory Board and the Management Board of Geratherm Medical AG resolved to use the authorization granted by the…

In the update to the study on the Geratherm Group published today by AlsterResearch, the upside target of EUR 11.30 can be maintained, despite the rise in energy prices and personnel costs.

Via…

The study on the Geratherm Group published by AlsterResearch on July 21, 2022 and the determined price target of EUR 11.00 have now been raised to EUR 11.30 following an update on 09/21/2022. The main…

Geratal, 07/21/2022. Entitled “A fresh start in a new segment – ​​Initiate with BUY” AlsterResearch published their study about the Geratherm Group today. Geratherm Medical is assessed by…

Geratal, May 11, 2022. Today JotWe GmbH, based in Steinbach am Wald, has today published an offer document for the voluntary public takeover bid for all shares in Geratherm Medical AG, Geratal (ISIN:…

Geratal, 13. April 2022. The Management Board of Geratherm Medical AG, Geratal (ISIN: DE0005495626) today resolved, with the approval of the Supervisory Board, to increase the Company's issued share…

Geratal, April 7, 2022: Geratherm Medical AG (ISIN: DE0005495626) had a stable sales trend in 2021 after the record year 2020. The result was burdened by the one-off expenses of the discontinuation of…